Atlantic Cancer Research Institute, Pavillon Hôtel-Dieu, 35 Providence Street, Moncton, NB, E1C 8X3, Canada.
Department of Chemistry and Biochemistry, Université de Moncton, Moncton, New Brunswick, Canada.
Sci Rep. 2021 Jan 15;11(1):1537. doi: 10.1038/s41598-021-81000-5.
PAX5 and EBF1 work synergistically to regulate genes that are involved in B lymphocyte differentiation. We used the KIS-1 diffuse large B cell lymphoma cell line, which is reported to have elevated levels of PAX5 expression, to investigate the mechanism of EBF1- and PAX5-regulated gene expression. We demonstrate the lack of expression of hallmark B cell genes, including CD19, CD79b, and EBF1, in the KIS-1 cell line. Upon restoration of EBF1 expression we observed activation of CD19, CD79b and other genes with critical roles in B cell differentiation. Mass spectrometry analyses of proteins co-immunoprecipitated with PAX5 in KIS-1 identified components of the MLL H3K4 methylation complex, which drives histone modifications associated with transcription activation. Immunoblotting showed a stronger association of this complex with PAX5 in the presence of EBF1. Silencing of KMT2A, the catalytic component of MLL, repressed the ability of exogenous EBF1 to activate transcription of both CD19 and CD79b in KIS-1 cells. We also find association of PAX5 with the MLL complex and decreased CD19 expression following silencing of KMT2A in other human B cell lines. These data support an important role for the MLL complex in PAX5-mediated transcription regulation.
PAX5 和 EBF1 协同作用,调节参与 B 淋巴细胞分化的基因。我们使用 KIS-1 弥漫性大 B 细胞淋巴瘤细胞系,该细胞系报道称 PAX5 表达水平升高,来研究 EBF1 和 PAX5 调节基因表达的机制。我们证明了在 KIS-1 细胞系中缺乏标志性 B 细胞基因的表达,包括 CD19、CD79b 和 EBF1。在恢复 EBF1 表达后,我们观察到 CD19、CD79b 和其他在 B 细胞分化中具有关键作用的基因被激活。与 PAX5 在 KIS-1 中共同免疫沉淀的蛋白质的质谱分析鉴定了 MLL H3K4 甲基化复合物的成分,该复合物驱动与转录激活相关的组蛋白修饰。免疫印迹显示,在存在 EBF1 的情况下,该复合物与 PAX5 的结合更强。沉默 KMT2A,即 MLL 的催化成分,抑制了外源性 EBF1 在 KIS-1 细胞中激活 CD19 和 CD79b 转录的能力。我们还发现,在其他人类 B 细胞系中沉默 KMT2A 后,PAX5 与 MLL 复合物的关联以及 CD19 表达的降低。这些数据支持 MLL 复合物在 PAX5 介导的转录调控中的重要作用。